FRANKFURT (Reuters) -BioNTech should be able to adapt its coronavirus vaccine relatively quickly in response to the Omicron variant, and the next few weeks will show how urgently an upgrade is needed, ...

Since the early stages of the COVID-19 vaccine rollout in the U.S., vaccine skeptics have used outdated interviews to spread claims that executives are refusing shots developed by their own ...

Dr. Ugur Sahin has been vaccinated against COVID-19. The original video in this post is from December 2020, before Sahin was eligible to be vaccinated under Germany’s priority rules. See the sources ...

FRANKFURT (Reuters) -BioNTech and Pfizer's COVID-19 vaccine will likely offer strong protection against any severe disease from the new Omicron virus variant, BioNTech's Chief Executive told Reuters, ...

With the omicron variant fueling new COVID-19 concerns, the CEO of leading vaccine player BioNTech says he's not sure whether a different shot will be needed to protect against the new strain. “This ...

The scientist who helped develop the Pfizer-BioNTech COVID-19 vaccine said a new version of the shot may be needed next year to protect against the virus. Dr. Ugur Sahin, BioNTech’s co-founder and CEO ...

BioNTech CEO Ugur Sahin is taking a big pay cut in 2021, but his large stake in the German company he co-founded still qualifies him for billionaire status. Sahin received a pay package worth 11.59 ...

The omicron variant of the coronavirus could lead to more infections among vaccinated people but they will most likely remain protected from a severe course of illness, according to the inventor of ...

He has conquered Covid for the time being, and now the CEO of BioNTech says he wants to turn his attention back to his first interest: cancer. Dr. Ugur Sahin is trying out the same mRNA technology ...

Says vaccine can be re-designed quickly if needed Says Omicron should require reworked vaccine at some point CEO: Any production expansion requires BioNTech's hands-on help FRANKFURT, Dec 3 (Reuters) ...

Since the early stages of the COVID-19 vaccine rollout in the U.S., vaccine skeptics have used outdated interviews to spread claims that executives are refusing shots developed by their own ...